Paweł Grzesiowski
- Molecular Medicine top 5%
- Infectious Diseases top 5%
- Clostridium difficile and Clostridium perfringens research 7
- Viral gastroenteritis research and epidemiology 3
- Endocrinology top 10%
- Diphtheria, Corynebacterium, and Tetanus 3
- Microbiology top 5%
-
- Pneumonia and Respiratory Infections 6
- Pneumocystis jirovecii pneumonia detection and treatment 3
- Respiratory viral infections research 3
-
- Gut microbiota and health 5
-
- Toxin Mechanisms and Immunotoxins 2
- Co-authors
- Waleria HryniewiczMarek GniadkowskiTomasz DzieciątkowskiGrzegorz BasakJarosław BilińskiEwa SadowyW Wiktor-JędrzejczakNikolaj Sørensen
- Journals
- Blood (1 paper)Clinical Infectious Diseases (1 paper)Journal of Clinical Microbiology (1 paper)
- Partner nations
- PolandUnited StatesCzechia
In The Last Decade
Paweł Grzesiowski
31 papers receiving 568 citations
Peers
Comparison fields: 5 of 78
- Molecular Medicine 113
- Infectious Diseases 307
- Applied Microbiology and Biotechnology 30
- Endocrinology 61
- Microbiology 70
Countries citing papers authored by Paweł Grzesiowski
This map shows the geographic impact of Paweł Grzesiowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paweł Grzesiowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paweł Grzesiowski more than expected).
Fields of papers citing papers by Paweł Grzesiowski
This network shows the impact of papers produced by Paweł Grzesiowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paweł Grzesiowski. The network helps show where Paweł Grzesiowski may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paweł Grzesiowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2022 | 15 | |
| 3 | 2020 | 12 | |
| 4 | 2020 | 15 | |
| 5 | 2017 | 35 | |
| 6 | 2017 | 196 | |
| 7 | 2012 | 11 | |
| 8 | 2011 | 8 | |
| 9 | 2011 | 3 | |
| 10 | 2008 | 20 | |
| 11 | 2007 | 4 | |
| 12 | Co zmieni się po 1 maja 2004 ? Bezpieczeństwo polskich szpitali a regulacje Unii Europejskiej – przewodnik, cz. I | 2004 | 0 |
| 13 | Rola rekomendacji i wytycznych w profilaktyce i terapii zakażeń | 2004 | 1 |
| 14 | 2004 | 8 | |
| 15 | 2004 | 53 | |
| 16 | 2001 | 7 | |
| 17 | 2001 | 10 | |
| 18 | 2000 | 29 | |
| 19 | [Immunity against diphtheria and tetanus in the adult Polish population]. | 2000 | 5 |
| 20 | 1997 | 25 |
About Paweł Grzesiowski
Paweł Grzesiowski is a scholar working on Endocrinology, Infectious Diseases and Applied Microbiology and Biotechnology, having authored 33 papers that have together received 594 indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (7 papers), Pneumonia and Respiratory Infections (6 papers), Gut microbiota and health (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Viral gastroenteritis research and epidemiology (3 papers), Diphtheria, Corynebacterium, and Tetanus (3 papers), Respiratory viral infections research (3 papers) and Toxin Mechanisms and Immunotoxins (2 papers). The work is most often cited by research in Molecular Medicine (113 citations), Infectious Diseases (307 citations) and Applied Microbiology and Biotechnology (30 citations). Paweł Grzesiowski has collaborated with scholars based in Poland, United States and Czechia. Frequent co-authors include Waleria Hryniewicz, Marek Gniadkowski, Tomasz Dzieciątkowski, Grzegorz Basak, Jarosław Biliński, Ewa Sadowy, W Wiktor-Jędrzejczak, Nikolaj Sørensen, Jadwiga Dwilewicz‐Trojaczek and Marta Wróblewska. Their work appears in journals such as Blood, Clinical Infectious Diseases and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.